Search

Thrombectomy Devices Market Survey Report – Recent Trends, Growth Opportunities, and Market Size and Share Global Forecast Analysis – 2024 - 2033

Thrombectomy Devices Market Trends, Growth Opportunity, and Forecast Analysis, 2024-2033

Thrombectomy Devices market revenue to generate USD 3.19 Billion by 2033, according to KDMI analyst’s growth analysis. The market is segmented by type, by application, by end-user, and by Region.

Thrombectomy Devices Market Size Survey Report – In a Glance

As per the survey report on global Thrombectomy Devices market, the market is projected to foresee a CAGR of 6.9% between 2024-2033, and further generate a market size of USD 3.19 billion by the end of 2033. In the year 2023, the market size was valued at USD 1.44 billion.

  • The global Thrombectomy Devices market is projected to grow on account of the Rising cases of cardiovascular diseases.
  • In Japan, the Thrombectomy Devices market growth can be attributed to the Growing Aging Population.
  • KDMI analyst’s growth analysis foresees High Cost Associated with Devices to challenge the market growth.
  • The North America Thrombectomy Devices market is projected to dominate the global market.

Thrombectomy Devices Market Analysis

Thrombectomy devices are a type of medical devices that are designed to remove blood clots that are formed in arteries or veins, also primarily used to treat conditions like stroke or deep vein thrombosis. These devices work by various mechanisms such as high-flow volume capped aspiration and self-expanding mesh discs to restore blood flow and prevent severe complications. The global Thrombectomy Devices market is expected to grow due to the rising cases of cardiovascular diseases. The number of people suffering from cardiovascular diseases is increasing rapidly due to factors such as changing lifestyle, an ageing population and growing population.  Integration of junk food in diet has become the primary factor to an unhealthy lifestyle, which results in various health issues including cardiovascular diseases. Development and technological advancement in thrombectomy devices contribute to the treatment of the condition by minimal invasive technique by resulting in enhance patient outcomes. According to a survey, around 620 million people are suffering from heart and circulatory diseases across the globe, which fuels the demand for these devices in the market, driving the market growth. Abbott Laboratories, Acandis GmbH, and Angio Dynamics, are some of the significant parties in the global market for Thrombectomy Devices.


Analyst’s Observation on Japan Thrombectomy Devices Market Survey

In Japan, the market growth for Thrombectomy Devices can be attributed to the Growing Aging Population. As Japan continue to have the world’s most aging population demographic, the increase in the number of elderly population results in increased heart and brain strokes condition. The elder population being more susceptible to these conditions like brain stroke, blood clotting, cardiovascular diseases, which requires thrombectomy procedures to treat the underlying conditions. According to reports, in 2022 approximately 232.96 thousand deaths were recorded in Japan due to heart diseases, the requirement of these devices increases, driving the market growth. Otsuka, Medco’s Hirat, and Akura Medical are some of the significant parties in the market for Thrombectomy Devices in Japan.


Thrombectomy Devices Market: Report Scope

Base Year

     2023

Base Year Market Size

     USD 1.44 Billion

Forecast Year

     2024-2033

Forecast Year Market Size

     USD 3.19 Billion

CAGR Value

    6.9%

Thrombectomy Devices Market Key Trends/Major Growth Drivers

  • Rising cases of cardiovascular diseases
  • Technological advancement in healthcare industry
  • Growing Aging Population to drive market growth in Japan

Restraint Factors

  • High Cost Associated with Devices
  • Lack of Skilled Professional

Thrombectomy Devices Market Segmentation

  • By Product Type
  • By Application
  • By End-Use
  • By Geography

Thrombectomy Devices Market Key Players

Abbott Laboratories, Acandis GmbH, Angio Dynamics, Boston Scientific Corporation, Cook Medical, Edwards Lifesciences Corporation, Johnsen & Johnsen Services Inc., Koninklijke Philips NV, Lemaitre Vascular Inc., Medtronic Plc., Penumbra Inc., Stryker Corporation, and others.


Thrombectomy Devices Market Growth Drivers and Challenges

Technological advancement in healthcare industry:

Healthcare industries are inclining more towards technological techniques involving the usage of thrombectomy device technology to deal with conditions such as blood clotting by improved clot retrieval rates, enhanced safety profile and minimal invasive procedures, which contribute to the market growth.

Lack of Skilled Professional:

Performing thrombectomy technique requires special training. The lack of trained healthcare profession who are capable of performing this procedure affects the market growth.


Thrombectomy Devices Market Segmentation

Our experts at KD Market Insights have segmented the global Thrombectomy Devices market research report as:

By Product Type

  • Ultrasound-assisted Thrombectomy Devices Rotational Thrombectomy Devices Aspiration Thrombectomy Devices Mechanical/Fragmentation Thrombectomy Devices Clot Extraction Catheter Stent Retrievers Microcatheters Others

By Application

  • Peripheral Thrombectomy Neurovascular Thrombectomy Cardiovascular Thrombectomy

By End-Use

  • Hospitals
  • Ambulatory Surgical Centers
  •  Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Malaysia
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa

Thrombectomy Devices Market Regional Synopsis

The North America Thrombectomy Devices market is majorly driven by the increasing senior population range and the chronic conditions related to blood clotting resulting in life-threatening conditions or cardiovascular diseases. The rise in number of death rates in U.S. due to heart strokes is the main reason for the rising usage of advanced technologies in healthcare industry of United States. In Canada region thrombectomy procedure is used to treat the coronary disease of heart and stroke diseases of brain. In 2023, The United States was recorder with 140,000 deaths per year, due to strokes, which drives the growth of the market.

As per our analysts at KD Market Insights, the following five players lead the North America Thrombectomy Devices market growth:

  • Boston Scientific Corporation
  • Stryker Corporation
  • Merit Medical Systems, Inc.,
  • Abbott
  • Dickinson & Company

Key Countries to Watch for in North America Thrombectomy Devices Market

Key Insights

U.S. Thrombectomy Devices Market to Register the Largest Regional Market Share in 2033

USD 0.66 billion

Canada Thrombectomy Devices Market to Grow with the Highest CAGR During 2024-2033

7.7%


Thrombectomy Devices Market Competitive Landscape

Some of the key players who top the global Thrombectomy Devices market share:

  • Abbott Laboratories
  • Acandis GmbH
  • Angio Dynamics
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Johnsen & Johnsen Services Inc.
  • Koninklijke Philips NV
  • Lemaitre Vascular Inc.
  • Medtronic Plc.
  • Penumbra Inc.
  • Stryker Corporation

Thrombectomy Devices Market Recent Developments

  • Penumbra Launches Lightning Flash 2.0 – Latest CAVT Technology Designed to Rapidly Remove Blood Clots. Lightning Flash™ 2.0, the next generation computer assisted vacuum thrombectomy (CAVT) system to remove venous thrombus and treat pulmonary emboli (PE). Lightning Flash 2.0 features advanced Lightning Flash algorithms, designed for increased speed and sensitivity to thrombus and blood flow.
  • Cerenovus, part of Johnson & Johnson MedTech, has announced the launch of its Cereglide 71 device—a next-generation intermediate catheter with TruCourse technology indicated for the revascularisation of patients suffering from acute ischaemic stroke. The device is now commercially available in the USA.

  1. Executive Summary
    1. Market Overview
    2. Key Findings
    3. Market Trends
    4. Market Outlook
  2. Introduction
    1. Scope of the Report
    2. Research Methodology
    3. Definitions and Assumptions
    4. Acronyms and Abbreviations
  3. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Challenges
  4. Global Thrombectomy Devices Market
    1. Market Overview
    2. Market Size and Forecast
    3. Market Segmentation
      1. By Product Type
      2. By Application
      3. By End Use
      4. By Region
  5. Market Segmentation by Product Type
    1. Ultrasound-assisted Thrombectomy Devices
    2. Rotational Thrombectomy Devices
    3. Aspiration Thrombectomy Devices
    4. Mechanical/Fragmentation Thrombectomy Devices
    5. Clot Extraction Catheter
    6. Stent Retrievers
    7. Microcatheters
    8. Others
  6. Market Segmentation by Application
    1. Peripheral Thrombectomy
    2. Neurovascular Thrombectomy
    3. Cardiovascular Thrombectomy
  7. Market Segmentation by End Use
    1.  Hospitals
    2. Ambulatory Surgical Centers
    3. Others
  8. Regional Analysis
    1. North America
      1. United States
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      2. Canada
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      3. Mexico
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
    2. Europe
      1. United Kingdom
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      2. Germany
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      3. France
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      4. Italy
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      5. Spain
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      6. Rest of Europe
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
    3. Asia Pacific
      1. China
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      2. Japan
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      3. India
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      4. Australia
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      5. South Korea
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      6. Rest of Asia Pacific
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
    4. Latin America
      1. Brazil
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      2. Argentina
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      3. Colombia
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      4. Rest of Latin America
        1. Market Size and Forecast
        2. Key Trends and Developments
        3.               Market Analysis by Product Type, by application and by end use
    5. Middle East & Africa
      1. South Africa
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      2. Saudi Arabia
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      3. UAE
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
      4. Rest of Middle East & Africa
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product Type, by application and by end use
  9. Competitive Landscape
    1. Market Share Analysis
    2. Company Profiles
      1.  Abbott Laboratories
      2. Acandis GmbH
      3. Angio Dynamics
      4. Boston Scientific Corporation
      5. Cook Medical
      6. Edwards Lifesciences Corporation
      7. Johnsen & Johnsen Services Inc.
      8. Koninklijke Philips NV
      9. Lemaitre Vascular Inc.
      10. Medtronic Plc.
      11. Penumbra Inc.
      12. Stryker Corporation
  10. Strategic Recommendations
  11. Appendix
    1. List of Tables
    2. List of Figures
  12. References

Need Customized Report for Your Business ?

Utilize the Power of Customized Research Aligned with Your Business Goals

Request for Customized Report

REQUEST FOR SAMPLE

- ISO Certified Logo -


Frequently Asked Questions(FAQ)

The global Thrombectomy Devices market is expected to cross a value of USD 3.19 billion by the end of 2033.

The global Thrombectomy Devices market was valued at USD 1.44 billion in 2023.

Over the mid-term, the Rising cases of cardiovascular diseases is the primary factor anticipated to drive the global Thrombectomy Devices market.

The global Thrombectomy Devices market is segmented by type, by application, by end-user, and by geography.

The North America Thrombectomy Devices market is projected to dominate the global market in 2033.

Some of the key players in the Thrombectomy Devices market include Abbott Laboratories, Acandis GmbH, Angio Dynamics, Boston Scientific Corporation, Cook Medical, and Edwards Lifesciences Corporation, among others.

-: Our Clients :-

Subscribe to Our Company Updates

* We will not share your personal information with anyone
Go Up